BenchSci vs Iambic Therapeutics
BenchSci vs Iambic Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BenchSci is on 64/100 and Iambic Therapeutics on 61/100.
Where each one leads
BenchSci
- domain rating: 60/100 against 48/100
- headcount: 274 against 151
- funding raised: $197M against $50.0M
- LinkedIn following: 32,822 against 17,283
Iambic Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BenchSci | Iambic Therapeutics |
|---|---|---|
| What it is | AI-powered platform for understanding disease biology and accelerating drug discovery. | AI-driven drug discovery company developing novel medicines for unmet patient needs. |
| Category | Biotech, Drug Discovery, AI-Driven Drug Discovery, Neuro-Symbolic AI | Biotech, HealthTech, Drug Discovery, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2015 | 2019 |
| Headquarters | Toronto, Canada | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BenchSci | Iambic Therapeutics |
|---|---|---|
| Employees | 274 | 151 |
| Headcount growthLast 12 months | -9.7% | Not published |
| Total funding | $197M | $50.0M |
| Latest round | Series D | Series B Extension |
| LinkedIn followers | 32,822 | 17,283 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BenchSci | Iambic Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 61/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 10/100 | 15/100 |
| Search visibility | 38/100 | 36/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (34/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 60/100 | 48/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BenchSci | Iambic Therapeutics |
|---|---|---|
| Hosting | Vercel | Not detected |
| CDN | Vercel | Cloudflare |
| CMS | Not detected | Webflow |
| Frameworks | Next.js, Tailwind CSS | Not detected |
What users say
| Measure | BenchSci | Iambic Therapeutics |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 1.0/5 from 1 vote | Not published |
BenchSci vs Iambic Therapeutics: common questions
Which is better, BenchSci or Iambic Therapeutics?
On our 0-100 score BenchSci rates higher (64/100 against 61/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do BenchSci and Iambic Therapeutics compare on the numbers?
BenchSci leads on domain rating (60/100 against 48/100), headcount (274 against 151), funding raised ($197M against $50.0M), LinkedIn following (32,822 against 17,283).
Read the full BenchSci review and pricing or the Iambic Therapeutics review and pricing. You can also browse other BenchSci alternatives we track.